MedCity News

APRIL 28, 2025

SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. The post Merck KGaAs Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition appeared first on MedCity News.

FDA 245

FDA Biopharma Pharma 245

PharmaVoice

APRIL 28, 2025

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

FDA 170

FDA Pharma 170

MedCity News

APRIL 28, 2025

The status quo for medical malpractice insurance is no longer good enough. While we must always prioritize the need for accountability when it comes to medical malpractice, we must also consider how challenges like increased premiums, rising costs and new risks are impacting providers and consequentially patients. The post Its Time for Medical Malpractice Insurance to Emerge from the Stone Age appeared first on MedCity News.

Insurance 243

Insurance Medical Patients Physicians 243

Pharma Marketing Network

APRIL 28, 2025

Introduction Imagine standing at the edge of a revolution, where every tool you need to succeed is finally within reach. That’s precisely where pharmaceutical marketers find themselves today. Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations.

Marketing 59

Marketing Pharma Education Networking 59

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

MedCity News

APRIL 28, 2025

[Sponsored] For many people, migraines interfere with daily life, work and relationships. Understanding whats behind them and how to manage them naturally can be a powerful step toward lasting relief. The post The Best Way to Manage Migraines Without Medication appeared first on MedCity News.

Management 241

Management Medical Healthcare Healthcare 241

MedCity News

APRIL 28, 2025

The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to consider. The post Value-Based Care Gets Real appeared first on MedCity News.

240

240

PharmaVoice

APRIL 28, 2025

BMS hopes to broaden the applications for the new schizophrenia drug into areas such as Alzheimer’s disease.

130

130

Referral MD

APRIL 28, 2025

Research shows that 93% of patients prefer to use technology when communicating with medical practices. Yet, 61% of health insurance claims are denied due to errors originating in patient intake forms. This disconnect highlights a critical gap in healthcare administrationone that modern intake and scheduling solutions are well-positioned to address.

Patients 52

Patients Healthcare Healthcare Insurance 52

Pharmaceutical Technology

APRIL 28, 2025

Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.

Manufacturing 108

Manufacturing 108

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

pharmaphorum

APRIL 28, 2025

The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr

Medicine 90

Medicine 90

Copyright Clearance Center

APRIL 28, 2025

The post Innovation, Governance, and Public Trust: The US Office of Management and Budget (OMB) Issues Guidance on AI appeared first on Copyright Clearance Center.

Government 90

Government Management 90

PM360

APRIL 28, 2025

April 15, 2025, New York, NY Inizio Evoke, a leading global health marketing, communications, and transformation platform, announced today the appointment of Tristen George and Kevin Kaniuga to the role of Executive Creative Director, further strengthening the agencys creative leadership as it continues to evolve its offering and elevate the standard of omnichannel engagement for health brands.

Leads 52

Leads Healthcare Healthcare Networking 52

pharmaphorum

APRIL 28, 2025

Does the Novavax delay augur a COVID vaccine policy change? Jonah.

66

66

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

Spotio

APRIL 28, 2025

Struggling with surface-level conversations that stall your deals? Youre not alone. Many field sales teams find themselves stuck in a cycle of missed opportunities, often because discovery calls rely too heavily on closed-ended questions. If you want to accelerate your pipeline and consistently close more deals, mastering open-ended sales questions is essential.

Sales 64

Sales Leads Prospecting Sales process 64

pharmaphorum

APRIL 28, 2025

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD)

66

66

Pharmacy Times

APRIL 28, 2025

Panelists discuss how statin therapy for primary prevention requires careful consideration of cardiovascular risk factors against potential adverse effects such as myalgia and liver abnormalities, generally favoring treatment when the calculated 10-year atherosclerotic cardiovascular disease [ASCVD] risk exceeds 7.5% to10% and adjusting recommendations based on individual patient factors including age, comorbidities, and preferences.

Patients 26

Patients 26

Pharmaceutical Technology

APRIL 28, 2025

The FDA has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's disease.

FDA 59

FDA 59

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

pharmaphorum

APRIL 28, 2025

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion.

59

59

Pharmaceutical Commerce

APRIL 28, 2025

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.

Pharma 52

Pharma 52

PharmExec

APRIL 28, 2025

Tiara Green, president, Accessia Health, highlights key themes from the upcoming discussion on how health equity, literacy, and social determinants are reshaping patient careespecially for those with chronic and rare conditions.

Education 52

Education Patients 52

Pharmaceutical Commerce

APRIL 28, 2025

Tiara Green, president, Accessia Health, highlights key themes from the upcoming discussion on how health equity, literacy, and social determinants are reshaping patient careespecially for those with chronic and rare conditions.

Education 52

Education Patients 52

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

PharmExec

APRIL 28, 2025

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.

Pharma 52

Pharma 52

Pharmaceutical Commerce

APRIL 28, 2025

Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.

Pharma 52

Pharma Patients 52

PharmExec

APRIL 28, 2025

Blake Powers, CEO, Medigi, discusses how face-to-face collaboration and streamlined commercialization strategies are helping life sciences companies deliver therapies more efficiently to patients.

Pharma 52

Pharma Patients 52

PharmaTech

APRIL 28, 2025

The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.

52

52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Technology

APRIL 28, 2025

The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC).

Marketing 52

Marketing 52

Pharmaceutical Commerce

APRIL 28, 2025

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of Theratechnologies, describes the uneasiness behind regulatory complications.

Pharma 52

Pharma 52

Pharmaceutical Technology

APRIL 28, 2025

Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks Therapeutics.

52

52